Number of Patients Who Develop Significant Drug-related Adverse Events. [clinicaltrials_resource:NCT00250432/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Number of Patients Who Develop Significant Drug-related Adverse Events. [clinicaltrials_resource:NCT00250432/outcome/1]
Bio2RDF identifier
NCT00250432/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00250432/outcome/1
analysis [clinicaltrials_vocabulary:analysis]
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
All patients as treated population
Full Analysis Set (FAS): Inclu ...... e, as defined in the protocol.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
type [clinicaltrials_vocabulary:type]
alternate
Number of Patients Who Develop Significant Drug-related Adverse Events.
@en
identifier
clinicaltrials_resource:NCT00250432/outcome/1
title
Number of patients with at lea ...... st-caspofungin therapy period.
@en
type
label
Number of Patients Who Develop ...... esource:NCT00250432/outcome/1]
@en